Page 35 - ARNM-3-1
P. 35
Advances in Radiotherapy
& Nuclear Medicine Chinese Expert Consensus for LACC
31. Chen J, Han Y, Hu Y, et al. Neoadjuvant camrelizumab plus Oncol. 2024;25(1):76-85.
chemotherapy for locally advanced cervical cancer (NACI
Study): A study protocol of a prospective, single-arm, phase doi: 10.1016/S1470-2045(23)00531-4
II trial. BMJ Open 2023;13(5):e067767. 33. Mayadev JS, Enserro D, Lin YG, et al. Sequential ipilimumab
doi: 10.1136/bmjopen-2022-067767 after chemoradiotherapy in curative-intent treatment of
patients with node-positive cervical cancer. JAMA Oncol.
32. Li K, Chen J, Hu Y, et al. Neoadjuvant chemotherapy plus 2020;6(1):92-99.
camrelizumab for locally advanced cervical cancer (NACI
study): A multicentre, single-arm, phase 2 trial. Lancet doi: 10.1001/jamaoncol.2019.3857
Volume 3 Issue 1 (2025) 27 doi: 10.36922/arnm.4032
